Citichem India Limited (BSE SME)
Dec 27, 2024 - Dec 31, 2024
| Price | ₹70 - ₹70 |
| Premium | ₹15 |
|---|---|
| Lot size | 2000 |
| Allotment | Jan 1, 2025 |
| Listing | Jan 3, 2025 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 2000 | 140000 | 427 |
| HNI | 2 | 4000 | 280000 | 427 |
Last updated on 31-Dec-2024 17:13:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| HNIs | 854000 | 243926000 | 285.63 |
| Retail | 854000 | 463872000 | 543.18 |
| Total | 1708000 | 701270000 | 410.58 |
| Total Applications: 311039 | |||
| HNI Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹26.8 | @8% ₹30.7 | @9% ₹34.5 | @10% ₹38.3 | @11% ₹42.2 | @12% ₹46 |
IPO Reservation
| Category | Shares Offered | No. of Shares |
|---|---|---|
| Retail | 47.5% | 854000 |
| Other | 47.5% | 854000 |
| Market Maker | 5.00% | 92000 |
| Total No. of Shares | 100.0% | 1800000 |
Citichem India IPO Details
| Issue Size | 18,00,000 shares (aggregating up to ₹12.60 Cr) |
| Fresh Issue | 18,00,000 shares (aggregating up to ₹ 12.60 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 50,00,000 shares |
| Share Holding Post Issue | 68,00,000 shares |
| Market Maker Portion | 92,000 shares |
| Market Maker | Aftertrade Broking |
Key Performance Indicator
| KPI | Jun-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 2.68% | 15.42% | 5.91% |
| ROCE | 3.30% | 21.47% | 7.89% |
| RONW | 2.68% | 15.42% | 5.91% |
| D/E | 0.15 | 0.15 | 0.18 |
| EPS (basic) | 0.40 | 2.24 | 0.81 |
| P/E Pre IPO | 31.3 | ||
| P/E Post IPO | 59.65 |
Company Financials In Lakhs.
| Period | Jun-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 6,852 | 6,933 | 7,973 | 9,143 |
| Revenue | 149 | 1,961 | 2,094 | 8,528 |
| Profit | 20 | 112 | 36 | 24 |
| Net Worth | 745 | 725 | 613 | 577 |
| Reserves | 245 | 225 | 113 | 77 |
| Borrowing | 108 | 108 | 110 | 111 |
About Company
Incorporated in 1992, Citichem India Limited is a supplier of organic and inorganic chemicals, bulk drugs, and food chemicals, catering primarily to the pharmaceutical industry. The company specializes in the direct supply of specialty chemicals, bulk drugs, and intermediate products, trading in chemicals and intermediates used across various industries, including aluminum, steel, textiles, paper, dairy, paints, dyes and intermediates, soap making, pharmaceuticals, food, and adhesives. Citichem India also offers food preservatives and chemicals under its brand, distributing them through a dedicated team to ensure safe and efficient delivery of bulk supplies. Its product portfolio includes items such as Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, and Hydrogen Peroxide, highlighting its broad reach and diverse applications across industrial sectors. As of June 30, 2024, The company has 9 employees.
Horizon Management Private Limited
Experienced Promoters and Management Team: Backed by decades of industry experience, the leadership ensures strategic growth and strong business relationships.
Scalable Business Model: The company’s diversified product range and presence across multiple industries enable significant scalability and market adaptability.
Focus on Quality and Innovation: Emphasis on delivering high-quality products and adopting innovative approaches drives customer satisfaction and long-term success.
Outstanding Legal Proceedings: Ongoing actions against the company, promoters, and directors could negatively impact its reputation, operations, and financial health if outcomes are unfavorable.so one should avoid this ipo
Regulatory Non-compliance: Instances of delayed filings under the Companies Act, 2013, may result in penalties or regulatory scrutiny.
Customer Concentration: Reliance on a few key customers makes the company vulnerable to financial risks if these customers reduce or stop purchases.
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: citichemindia.ipo@kfintech.com